OA12640A - Mycoplasma bovis vaccine methods of reducing pneumonia in animals. - Google Patents

Mycoplasma bovis vaccine methods of reducing pneumonia in animals. Download PDF

Info

Publication number
OA12640A
OA12640A OA1200300346A OA1200300346A OA12640A OA 12640 A OA12640 A OA 12640A OA 1200300346 A OA1200300346 A OA 1200300346A OA 1200300346 A OA1200300346 A OA 1200300346A OA 12640 A OA12640 A OA 12640A
Authority
OA
OAPI
Prior art keywords
bovis
mycoplasma
vaccine
challenge
mycoplasma bovis
Prior art date
Application number
OA1200300346A
Other languages
English (en)
Inventor
Robin Lee Keich
Robert John Yancey
David Ross Mcgavin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA12640A publication Critical patent/OA12640A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA1200300346A 2001-07-02 2002-06-27 Mycoplasma bovis vaccine methods of reducing pneumonia in animals. OA12640A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
OA12640A true OA12640A (en) 2006-06-15

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300346A OA12640A (en) 2001-07-02 2002-06-27 Mycoplasma bovis vaccine methods of reducing pneumonia in animals.

Country Status (31)

Country Link
US (1) US20030147914A1 (pt)
EP (1) EP1401488A1 (pt)
JP (1) JP2004536106A (pt)
KR (1) KR20040030783A (pt)
CN (1) CN1522152A (pt)
AP (1) AP2002002568A0 (pt)
AR (1) AR036125A1 (pt)
BG (1) BG108496A (pt)
BR (1) BR0210798A (pt)
CA (1) CA2452580A1 (pt)
CZ (1) CZ20033465A3 (pt)
EA (1) EA200301324A1 (pt)
GT (1) GT200200139A (pt)
HN (1) HN2002000162A (pt)
HR (1) HRP20031078A2 (pt)
HU (1) HUP0501188A2 (pt)
IL (1) IL159516A0 (pt)
IS (1) IS7078A (pt)
MA (1) MA27048A1 (pt)
MX (1) MXPA03011815A (pt)
NO (1) NO20035767L (pt)
OA (1) OA12640A (pt)
PA (1) PA8549801A1 (pt)
PE (1) PE20030239A1 (pt)
PL (1) PL373891A1 (pt)
SK (1) SK15802003A3 (pt)
TN (1) TNSN03154A1 (pt)
UY (1) UY27365A1 (pt)
WO (1) WO2003004052A1 (pt)
YU (1) YU102103A (pt)
ZA (1) ZA200309747B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
ES2535977T3 (es) 2006-09-11 2015-05-19 Zoetis P Llc Bacterinas tratadas térmicamente y vacunas en emulsión preparadas a partir de tales bacterinas tratadas térmicamente
UY31437A1 (es) * 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
CA2729080C (en) * 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
AU2009309041B2 (en) * 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2010140377A1 (ja) 2009-06-04 2010-12-09 独立行政法人産業技術総合研究所 マイコプラズマ感染症用ワクチン
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
CN115141772A (zh) 2015-08-14 2022-10-04 硕腾服务有限责任公司 牛支原体组合物
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP1229929A2 (en) * 1999-11-08 2002-08-14 Biomune VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
IS7078A (is) 2003-12-15
MXPA03011815A (es) 2004-04-02
PL373891A1 (en) 2005-09-19
CA2452580A1 (en) 2003-01-16
MA27048A1 (fr) 2004-12-20
CZ20033465A3 (cs) 2004-12-15
IL159516A0 (en) 2004-06-01
ZA200309747B (en) 2005-05-27
WO2003004052A1 (en) 2003-01-16
BR0210798A (pt) 2006-05-23
TNSN03154A1 (fr) 2005-12-23
PA8549801A1 (es) 2003-09-17
AP2002002568A0 (en) 2002-06-30
US20030147914A1 (en) 2003-08-07
BG108496A (en) 2005-02-28
CN1522152A (zh) 2004-08-18
AR036125A1 (es) 2004-08-11
UY27365A1 (es) 2003-04-30
HUP0501188A2 (en) 2006-05-29
EP1401488A1 (en) 2004-03-31
KR20040030783A (ko) 2004-04-09
EA200301324A1 (ru) 2004-12-30
JP2004536106A (ja) 2004-12-02
HRP20031078A2 (en) 2005-08-31
HN2002000162A (es) 2002-09-17
PE20030239A1 (es) 2003-03-21
GT200200139A (es) 2003-02-13
NO20035767L (no) 2004-01-30
YU102103A (sh) 2006-05-25
SK15802003A3 (sk) 2005-01-03

Similar Documents

Publication Publication Date Title
OA12640A (en) Mycoplasma bovis vaccine methods of reducing pneumonia in animals.
US7056492B2 (en) Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle
EP1474067B2 (en) One dose vaccination with i mycoplasma hyopneumoniae /i
AU2002309109A1 (en) One dose vaccination with mycoplasma hyopneumoniae
US20210369832A1 (en) Vaccine for protection against streptococcus suis
CA2457514A1 (en) Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
JP3178720B2 (ja) パスツレラ・ムルトシダのトキソイドワクチン
US20040170652A1 (en) Saponin inactivated mycoplasma vaccine
AU2002311568A1 (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
AU2002304305B2 (en) Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
AU2002313573A1 (en) Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
AU2002304305A1 (en) Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle